Wikipedia
Siponimod
Siponimod (or BAF312) is a selective sphingosine-1-phosphate receptor modulator for oral use that is an investigational drug for multiple sclerosis (MS). It is intended for once-daily oral administration.
it is in a phase III clinical trial for secondary progressive MS due to complete Dec 2016.